Zobrazeno 1 - 10
of 430
pro vyhledávání: '"Landgren, Ola"'
Autor:
Cirrincione AM; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Poos AM; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Kaddoura M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Bärtsch MA; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Chojnacka M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., John L; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Reichert P; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Huhn S; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Blaney P; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Gagler D; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Rippe K; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Zhang Y; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Davies F; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Goldschmidt H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Weisel KC; Department of Oncology, Hematology, and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mai EK; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Morgan GJ; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Raab MS; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
Publikováno v:
Blood [Blood] 2024 Aug 15; Vol. 144 (7), pp. 771-783.
Autor:
Landgren O; Division of Myeloma, Department of Medicine, Sylvester Myeloma Research Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Prior TJ; Janssen, Spring House, PA., Masterson T; Janssen, Spring House, PA., Heuck C; Janssen, Spring House, PA., Bueno OF; AbbVie, North Chicago, IL., Dash AB; Takeda, Lexington, MA., Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Goldschmidt H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Knop S; Nuremberg General Hospital and Paracelsus Medical School, Nuremberg, Germany., Li C; Takeda, Lexington, MA., Mellqvist UH; Södra Älvsborgs Hospital, Borås, Sweden., McFadden I; Amgen, Thousand Oaks, CA., Oprea C; Sanofi, Vitry-sur-Seine, France., Ross JA; AbbVie, North Chicago, IL., Talpes M; Amgen, Thousand Oaks, CA., Hydren JR; HealthTree Foundation, Lehi, UT., Ahlstrom JM; HealthTree Foundation, Lehi, UT., Kazandjian D; Division of Myeloma, Department of Medicine, Sylvester Myeloma Research Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Weinhold N; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Zhang R; Sanofi, Vitry-sur-Seine, France., Stetler-Stevenson M; National Cancer Institute, National Institutes of Health, Bethesda, MD., Marti G; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Devlin SM; Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood [Blood] 2024 Jul 25; Vol. 144 (4), pp. 359-367.
Autor:
Ziccheddu B; Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Giannotta C; Laboratory of Blood Tumor Immunology, Molecular Biotechnology Center 'Guido Tarone', Department of Molecular Biotechnology and Health Sciences, Università di Torino, Torino, Italy., D'Agostino M; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Bertuglia G; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Saraci E; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Oliva S; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Genuardi E; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Papadimitriou M; Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Diamond B; Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Corradini P; Division of Hematology and Bone Marrow Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Coffey D; Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Landgren O; Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Bolli N; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy., Bruno B; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Boccadoro M; European Myeloma Network, (EMN), Torino, Italy., Massaia M; Laboratory of Blood Tumor Immunology, Molecular Biotechnology Center 'Guido Tarone', Department of Molecular Biotechnology and Health Sciences, Università di Torino, Torino, Italy.; SC Ematologia, AO S. Croce e Carle, Cuneo, Italy., Maura F; Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA. fxm557@med.miami.edu., Larocca A; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Jul 19; Vol. 14 (1), pp. 117. Date of Electronic Publication: 2024 Jul 19.
Autor:
Meseha M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, 1120 NW 14th Street, Clinical Research Building, Miami, FL, 33136, USA., Hoffman J; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, 1120 NW 14th Street, Clinical Research Building, Miami, FL, 33136, USA., Kazandjian D; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, 1120 NW 14th Street, Clinical Research Building, Miami, FL, 33136, USA., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, 1120 NW 14th Street, Clinical Research Building, Miami, FL, 33136, USA., Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, 1120 NW 14th Street, Clinical Research Building, Miami, FL, 33136, USA. bxd500@med.miami.edu.
Publikováno v:
Current oncology reports [Curr Oncol Rep] 2024 Jun; Vol. 26 (6), pp. 679-690. Date of Electronic Publication: 2024 Apr 27.
Autor:
Maura F; Division of Myeloma, University of Miami, Miami, FL, USA. fxm557@med.miami.edu., Coffey DG; Division of Myeloma, University of Miami, Miami, FL, USA., Stein CK; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Braggio E; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Ziccheddu B; Division of Myeloma, University of Miami, Miami, FL, USA., Sharik ME; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Du MT; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Tafoya Alvarado Y; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Shi CX; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Zhu YX; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Meermeier EW; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Landgren O; Division of Myeloma, University of Miami, Miami, FL, USA., Bergsagel PL; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Chesi M; Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA. chesi.marta@mayo.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 May 07; Vol. 15 (1), pp. 3844. Date of Electronic Publication: 2024 May 07.
Autor:
Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Rajanna AR; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Poos AM; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Durante M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Papadimitriou M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Davies F; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Boyle EM; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Walker B; Division of Hematology Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN., Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Silva A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Hampton O; Aster Insights, Tampa, FL., Teer JK; Department of Biostatistics & Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, FL., Siegel EM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL., Bolli N; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy., Jackson GH; Freeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom., Kaiser M; The Institute of Cancer Research, London, United Kingdom., Pawlyn C; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Cook G; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Kazandjian D; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Stein C; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Chesi M; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Bergsagel L; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Mai EK; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Weisel KC; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Raab MS; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Van Rhee F; Myeloma Institute for Research & Therapy, University of Arkansas for Medical Sciences, Little Rock, AR., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shain KH; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Morgan G; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. 1229-1240. Date of Electronic Publication: 2024 Jan 09.
Autor:
Eythorsson E; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Rognvaldsson S; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Thorsteinsdottir S; Faculty of Medicine, University of Iceland, Reykjavík, Iceland, and Department of Hematology, Rigshospitalet, Copenhagen, Denmark (S.T.)., Einarsson Long T; Faculty of Medicine, University of Iceland, Reykjavík, Iceland, and Skåne University Hospital, Lund, Sweden (T.E.L.)., Reed ER; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Sigurdardottir GA; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Vidarsson B; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Onundarson PT; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Agnarsson BA; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Sigurdardottir M; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Olafsson I; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Thorsteinsdottir I; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Sveinsdottir SV; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Sigurdsson F; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Thordardottir AR; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Palsson R; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Indridason OS; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Jonsson A; Akureyri Hospital, Akureyri, Iceland (A.J.)., Gislason GK; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Olafsson A; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Sigurdsson J; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Steingrimsdottir H; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Hultcrantz M; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York (M.H.)., Durie BGM; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, California (B.G.M.D.)., Harding S; The Binding Site, Birmingham, West Midlands, United Kingdom (S.H.)., Landgren O; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida (O.L.)., Aspelund T; Center for Public Health Sciences, University of Iceland, Reykjavík, Iceland (T.A.)., Love TJ; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Kristinsson SY; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.).
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2024 Apr; Vol. 177 (4), pp. 449-457. Date of Electronic Publication: 2024 Apr 02.
Autor:
Chojnacka M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Rustad E; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Papadimitriou M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Boyle EM; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Blaney P; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Morgan G; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 01; Vol. 30 (3), pp. 575-585.
Autor:
Scheid C; University Hospital and Center for Integrated Oncology Cologne, Cologne, Germany., Landgren O; Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, Florida, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Feb; Vol. 204 (2), pp. 393-394. Date of Electronic Publication: 2024 Jan 02.
Autor:
Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. fxm557@med.miami.edu., Boyle EM; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Coffey D; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Gagler D; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Ghamlouch H; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Blaney P; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Cirrincione A; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Chojnacka M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Wang Y; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Siegel A; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Hoffman JE; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Kazandjian D; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Hassoun H; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Guzman E; Genome Technology Center, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Shah UA; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Tan C; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Scordo M; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah GL; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Landau H; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chung DJ; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Giralt S; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang Y; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arbini A; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Gao Q; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roshal M; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dogan A; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Davies FE; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Usmani SZ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA. Gareth.Morgan@nyulangone.org., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. col15@miami.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2023 Dec; Vol. 4 (12), pp. 1660-1674. Date of Electronic Publication: 2023 Nov 09.